Healthcare stocks were advancing pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.6% higher.

MeiraGTx (MGTX) shares were up more than 7% after the company reported that it swung to a Q2 net income as revenue surged during the period.

Cullinan Therapeutics (CGEM), Taiho Oncology and Taiho Pharmaceutical said a phase 3 clinical trial evaluating the combination of their jointly developed drug zipalertinib and chemotherapy as a first-line treatment for adults with previously untreated, locally advanced or metastatic non-small cell lung cancer met its primary endpoint of progression-free survival. Shares of Cullinan Therapeutics were up more than 7% premarket.

Ascendis Pharma (ASND) stock was up more than 1% after the company posted higher Q2 non-IFRS earnings and revenue.